Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 days

Yoshitaka Sato, Mitsutaka Iguchi, Yoshiaki Kato, Hiroshi Morioka, Aki Hirabayashi, Nobuyuki Tetsuka, Yuka Tomita, Daizo Kato, Kiyofumi Yamada, Hiroshi Kimura, Tetsuya Yagi

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 days'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology